HomeBNTX • NASDAQ
add
BioNTech
$96.25
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$96.25
Sarado: Dis 5, 4:00:28 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$96.00
Sakop ng araw
$95.21 - $96.69
Sakop ng taon
$81.20 - $129.27
Market cap
23.14B USD
Average na Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.52B | 22.02% |
Gastos sa pagpapatakbo | 1.40B | 34.32% |
Net na kita | -28.70M | -114.49% |
Net profit margin | -1.89 | -111.88% |
Kita sa bawat share | -0.12 | -114.81% |
EBITDA | 91.20M | 39.66% |
Aktuwal na % ng binabayarang buwis | 216.19% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.53B | -13.06% |
Kabuuang asset | 21.34B | -4.73% |
Kabuuang sagutin | 2.86B | -12.87% |
Kabuuang equity | 18.48B | — |
Natitirang share | 240.46M | — |
Presyo para makapag-book | 1.25 | — |
Return on assets | -0.38% | — |
Return on capital | -0.44% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -28.70M | -114.49% |
Cash mula sa mga operasyon | 780.70M | 222.19% |
Cash mula sa pag-invest | -925.30M | -551.16% |
Cash mula sa financing | -11.50M | -45.57% |
Net change in cash | -176.60M | 76.52% |
Malayang cash flow | 1.05B | 253.59% |
Tungkol
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
CEO
Itinatag
2008
Website
Mga Empleyado
6,772
